Terazol 3 (Janssen Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Terazol 3 drug offered from Janssen Pharmaceuticals, Inc.. This Azole Antifungal [EPC],Azoles [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Janssen Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | TERCONAZOLE |
SUBSTANCE NAME: | TERCONAZOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Azole Antifungal [EPC],Azoles [Chemical/Ingredient] |
ROUTE: | VAGINAL |
DOSAGE FORM: | SUPPOSITORY |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1988-05-24 |
END MARKETING DATE: | 0000-00-00 |
Terazol 3 HUMAN PRESCRIPTION DRUG Details:
Item Description | Terazol 3 from Janssen Pharmaceuticals, Inc. |
LABELER NAME: | Janssen Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 80(mg/1) |
START MARKETING DATE: | 1988-05-24 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 50458-531_7325732c-8475-4ed2-8189-4b9e2353be63 |
PRODUCT NDC: | 50458-531 |
APPLICATION NUMBER: | NDA019641 |
Other TERCONAZOLE Pharmaceutical Manufacturers / Labelers: